Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

In a new study reported in Science Advances, scientists analyzed MRI data stored at the UK Biobank and identified seven genes ...

Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...

Pharmaceutical Executive: Can you describe South Rampart’s work in pain medication? Dr. Hernan Bazan: For several years now, we've been working on the development of a novel manipulated small molecule ...

Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take up a human blood cell ...

Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a few years ago that its use became mainstream. Originally crafted to ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Preclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process.

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...